Home BHVN
loading

Biohaven Pharmaceutical Holding (BHVN) Latest News

Dec-02-22 10:00AM Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022Benzinga
Dec-01-22 08:31AM Jim Cramer Says This Stock Is Dynamite: 'I Do Not Want You To Do A Thing Other Than Ride It'Benzinga
06:20AM Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?Zacks Investment Research
Nov-29-22 09:35AM After Plunging 13% in 4 Weeks, Here's Why the Trend Might Reverse for Biohaven Ltd. (BHVN)Zacks Investment Research
Nov-28-22 09:55AM How Much Upside is Left in Biohaven Ltd. (BHVN)? Wall Street Analysts Think 54%Zacks Investment Research
Nov-09-22 08:35AM Biohaven Ltd. (BHVN) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research
Nov-08-22 06:20AM Should iShares Morningstar SmallCap Growth ETF (ISCG) Be on Your Investing Radar?Zacks Investment Research
Nov-01-22 06:20AM Should Vanguard Russell 2000 ETF (VTWO) Be on Your Investing Radar?Zacks Investment Research
Oct-31-22 01:50AM The Rally Accelerated Friday, Big Tech Lagged, BuySeeking Alpha
Oct-27-22 08:53AM $41 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are BuyingBenzinga
Oct-24-22 05:37AM Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From FridayBenzinga
04:19AM Moderna, Amazon, Tesla, And Other Big Gainers From FridayBenzinga
Oct-20-22 04:39AM Intuitive Surgical, Netflix, ASML And Other Big Gainers From WednesdayBenzinga
01:52AM Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From YesterdayBenzinga
Oct-12-22 10:02AM Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022Benzinga
Oct-11-22 02:17AM Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From YesterdayBenzinga
Oct-10-22 12:10PM Big-Cap S&P Stocks Will Soon Provide Tech-Like Returns, I ExplainSeeking Alpha
Oct-07-22 09:34AM Coinbase Global And 3 Other Stocks Insiders Are BuyingBenzinga
03:24AM Biohaven Ltd. (BHVN) Surges 7.6%: Is This an Indication of Further Gains?Zacks Investment Research
Oct-06-22 10:54AM Biohaven (BHVN) Stock Up on Spin-Off Transaction FinalizationZacks Investment Research
07:25AM Pinterest, Perion Network And Some Other Big Stocks Moving Higher In Today's Pre-Market SessionBenzinga
Oct-06-22 06:17AM Why WISeKey International Is Trading Higher By Over 20%; Here Are 29 Stocks Moving PremarketBenzinga
Oct-05-22 04:45AM Why Biohaven Stock Skyrocketed Again TodayThe Motley Fool
Oct-04-22 12:29PM Why Biohaven Stock Is Soaring TodayThe Motley Fool
Sep-30-22 01:04AM Biohaven Pharma's (BHVN) ALS Study Fail to Meet Both EndpointsZacks Investment Research
06:20AM Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?Zacks Investment Research
Sep-07-22 11:30AM Why Is Apellis Pharmaceuticals, Inc. (APLS) Down 9.8% Since Last Earnings Report?Zacks Investment Research
Sep-06-22 06:20AM Should iShares Morningstar SmallCap Growth ETF (ISCG) Be on Your Investing Radar?Zacks Investment Research
Aug-30-22 06:20AM Should iShares Morningstar SmallCap ETF (ISCB) Be on Your Investing Radar?Zacks Investment Research
Aug-23-22 08:50AM $5.6 Million Bet On This Healthcare Stock? 3 Stocks Insiders Are BuyingBenzinga
Aug-19-22 10:52AM Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022Benzinga
Aug-11-22 07:30AM Get ready for more merger mania in the pharma sector for the rest of the yearMarketWatch
Aug-09-22 04:46AM Get ready for more merger mania in the pharma sector for the rest of the yearMarketWatch
02:43AM Get ready for more merger mania in pharma sector the rest of the yearMarketWatch
Aug-08-22 02:50AM Why These Pfizer Analysts Like The Global Blood Therapeutics DealBenzinga
12:39PM Biohaven Pharmaceutical (BHVN) Q2 Earnings Lag, Sales BeatZacks Investment Research
Aug-08-22 10:10AM Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022Benzinga
Aug-07-22 01:25AM Teva Pharmaceutical: A Gem Among Generic Pharmaceutical CompaniesSeeking Alpha
Aug-05-22 08:15AM Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research
Aug-04-22 08:45AM Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research
Aug-03-22 07:02AM Doximity (DOCS) to Report Q1 Earnings: What's in the Offing?Zacks Investment Research
Biohaven Pharmaceutical Holding Company Ltd., a clinical-stage biopharmaceutical company, develops product candidates to treat neurological diseases, including rare disorders. Its lead product candidate is rimegepant, which is in Phase III clinical trials for the acute treatment of migraine. The company also develops trigriluzole, which is in a Phase II/III clinical trial used for the treatment of ataxias with an initial focus on spinocerebellar ataxia; and Phase II/III clinical trial for the treatment of obsessive compulsive disorders, as well as for the treatment of Alzheimer's diseases. In addition, it develops BHV-3500 for the acute treatment and prevention of migraine; BHV-0223 for the treatment of amyotrophic lateral sclerosis, a neurodegenerative disease that affects nerve cells in the brain and spinal cord; and BHV-5000 for the treatment of symptoms associated with Rett syndrome, such as breathing irregularities. The company was founded in 2013 and is based in New Haven, Connecticut. Biohaven Pharmaceutical Holding Company Ltd. is a subsidiary of Portage Biotech Inc.
Cap:    |  Volume (24h):